Yuanquan Yang
Clinical trials sponsored by Yuanquan Yang, explained in plain language.
-
New drug duo tested for tough bladder cancers
Disease control Recruiting nowThis study is testing a combination of two drugs, futibatinib and durvalumab, given before surgery to remove the bladder. It is for patients with muscle-invasive bladder cancer who cannot receive the usual chemotherapy due to other health problems like kidney issues or heart fail…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New approach aims to shield patients from dangerous side effects when restarting cancer treatment
Disease control Recruiting nowThis study is testing whether adding a drug called siltuximab can help cancer patients safely restart a type of immunotherapy that previously caused them severe side effects. The trial will enroll 40 adults with advanced cancer who had to stop their original immunotherapy due to …
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC